Bayer’s high hopes for new drug that prevents blood clots

Hopes are rising that Bayer’s blood-thinning pill, Rivaroxaban, could eventually become a standard treatment for preventing heart attacks, pulmonary embolisms and strokes.

Susan Mitchell

Deputy Editor and Health Editor @susmitchellsbp
9th August, 2008

Hopes are rising that Bayer’s blood-thinning pill, Rivaroxaban, could eventually become a standard treatment for preventing heart attacks, pulmonary embolisms and strokes.

Tens of thousands of Irish people might some day take it following surgery or to prevent blood clots from forming. EU regulators recommended approval of Rivaroxaban last month. Final approval from the European Commission is expected within months.

Henrik Wulff, managing director of Bayer Ltd in Ireland, said Rivaroxaban would ‘‘revolutionise...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month, €19.99 Monthly thereafter

Get basic

*New subscribers only

You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

The year in review

Legacy Richie Oakley 1 year ago

Newsround: What Thursday’s papers say

Legacy Leanna Byrne 5 years ago

More cycle routes, expansion of Luas to Bray and new bus network proposed

Legacy Digital Desk 5 years ago